What is the recommended titration schedule for donepezil (Aricept)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Donepezil Titration Protocol

The recommended titration schedule for donepezil is to start with 5 mg once daily in the evening for 4-6 weeks, then increase to 10 mg once daily if well tolerated, with potential escalation to 23 mg daily after at least 3 months on 10 mg for patients with moderate to severe Alzheimer's disease. 1, 2

Initial Dosing and Titration

  • Starting dose: 5 mg once daily in the evening, just prior to retiring 1
  • Timing: Take in the evening before bedtime 1
  • Administration: Can be taken with or without food 1
  • First titration: Increase to 10 mg once daily after 4-6 weeks on 5 mg 1, 2
  • Second titration (for moderate-severe AD only): Increase to 23 mg once daily after at least 3 months on 10 mg 1, 2

Titration Considerations

Gastrointestinal Side Effects Management

  • Most common adverse effects are gastrointestinal (nausea, vomiting, diarrhea) 2
  • These effects typically occur within the first 2 weeks of treatment or dose increase 3
  • Taking medication with food can help reduce GI side effects 2
  • Slower titration schedules reduce incidence of side effects 4, 3

Alternative Titration Methods for Higher Doses

For patients escalating to 23 mg daily, research suggests intermediate titration methods may improve tolerability:

  • Option 1: Increase to 15 mg daily for 4 weeks before escalating to 23 mg 3
  • Option 2: Alternate between 10 mg and 23 mg on consecutive days for 4 weeks before full escalation 3
  • These intermediate titration steps significantly reduced nausea compared to direct escalation 3

Monitoring During Titration

  • Assess for cholinergic side effects: nausea, vomiting, diarrhea, anorexia, headache, insomnia, muscle cramps 2
  • Monitor weight, as weight loss can occur 2
  • Evaluate for bradycardia, especially in patients with cardiac conditions 5
  • Assess for clinical benefit after 6-12 weeks through:
    • Physician assessment
    • Caregiver reports
    • Neuropsychological testing
    • Functional changes 2

Special Considerations

  • The 23 mg tablet should not be split, crushed, or chewed 1
  • Donepezil has a long half-life (60 hours in young adults, 104 hours in elderly) 6
  • Side effects are typically mild to moderate and transient 5, 4
  • No significant hepatotoxicity concerns (unlike tacrine) 4, 6
  • Limited drug interactions, but use caution with strong inducers of cytochrome P450 6

When to Consider Dose Reduction or Discontinuation

  • Persistent or severe gastrointestinal side effects 2
  • Weight loss >5% from baseline 2
  • Poor adherence 2
  • Continued deterioration at pre-treatment rate after 6-12 months 2

Following this titration protocol maximizes the potential cognitive and functional benefits of donepezil while minimizing adverse effects that could impact quality of life and medication adherence.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.